Niacinamide: Choose the Purpose Before the Percentage
Use published doses as development leads, then evaluate the vehicle, tolerability and finished-product evidence.
Our development perspective: Use published doses as development leads, then evaluate the vehicle, tolerability and finished-product evidence.
A percentage is a design variable
Competing serum percentages can turn development into a race for a larger number. Start instead with the desired appearance benefit, intended users and validation method. Niacinamide studies use different formulas, populations and endpoints; those conditions determine relevance.
Published doses answer different questions
Original studies have examined a 2% niacinamide moisturizer for facial sebum-related measurements and a 5% moisturizer for photoaged-skin appearance. They offer candidate levels and study-design leads, not a universal optimum or a ranking across unrelated formulas.[1,2]
Build a focused screening matrix
Compare a small number of candidate levels in closely matched vehicles for solubility, feel, stability and tolerance before fuller efficacy testing. Select levels from the brief, specifications and safety assessment. A larger label number does not justify an unverified benefit or poorer user experience.
CSFSRI formulation development: connect product objectives with appropriate validation.
Assess compatibility in the complete vehicle
A blanket compatibility rule for vitamin C is not a formulation assessment. Identify the actual vitamin C form and evaluate pH, temperature, packaging, colour and assay changes. No single pH window is the answer for every niacinamide product; use specifications and measured stability.
Manage quality and tolerance together
Niacinamide and nicotinic acid are distinct materials. Verify identity, assay and relevant impurities, but a purity certificate cannot establish universal product tolerability. Formula, application amount, frequency and individual factors all warrant assessment.
Bridge mechanism and claim with validation
Melanosome-transfer research provides mechanistic leads, not a consumer spot-reduction percentage. Tone appearance, shine and hydration claims require appropriate endpoints and market review; one endpoint does not establish every benefit.[3]
Purpose first, dose second
Give the manufacturer a positioning brief, intended users, use pattern, evaluation endpoints and sensory limits. Make concentration an evidence-led choice rather than a number fixed before development.
References and development perspective
We use the research and standards below to inform formulation decisions. We evaluate finished-product performance separately against the intended claims.
[1] The effect of 2% niacinamide on facial sebum production
[2] Niacinamide: A B vitamin that improves aging facial skin appearance